Medical Staff Portal
News, Alerts & Events

Dantrolene (Dantrium®) 20 mg injection - Shortage

May 07 , 2018

The Issue:

There is a back order dantrolene (Dantrium®) 20 mg injection. The only Canadian manufacturer of this product is Paladin Canada. The estimated availability date is late August 2018.

 Stock levels are low and will not meet current demands. Inventory will be depleted prior to the resolution of this back order.

 Key messages include:

  • Physicians should be aware of the shortage of dantrolene (Dantrium®) 20 mg injection.
  • There are no medication alternatives to dantrolene for the management of malignant hyperthermia.
  • Stock movement and supply sharing of dantrolene injection will be required.


Please post this notice in your area and ensure all staff are informed about the change.


Please contact your site pharmacy department with any questions or concerns.

Download PDF